News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
253,432 Results
Type
Article (16952)
Company Profile (30)
Press Release (236450)
Section
Business (66412)
Career Advice (714)
Deals (11842)
Drug Delivery (44)
Drug Development (38345)
Employer Resources (84)
FDA (6046)
Job Trends (5496)
News (123027)
Policy (10681)
Tag
2024 BioMidwest Digital (2)
2024 Bio NC Digital (2)
2024 Biotech Bay Standard (4)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (3)
2024 Pharm Country Standard (2)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (1309)
Academic (1)
Adcomms (7)
Allergies (33)
Alliances (18889)
ALS (45)
Alzheimer's disease (652)
Antibody-drug conjugate (ADC) (38)
Approvals (6061)
Artificial intelligence (101)
Autoimmune disease (4)
Automation (7)
Bankruptcy (94)
Best Places to Work (4749)
BIOSECURE Act (7)
Biosimilars (32)
Biotechnology (19)
Bladder cancer (33)
Brain cancer (13)
Breast cancer (139)
Cancer (913)
Cardiovascular disease (70)
Career advice (608)
Career pathing (14)
CAR-T (58)
Cell therapy (146)
Cervical cancer (10)
Clinical research (32567)
Collaboration (235)
Compensation (21)
Complete response letters (5)
COVID-19 (1413)
CRISPR (12)
C-suite (51)
Cystic fibrosis (22)
Data (989)
Denatured (17)
Depression (13)
Diabetes (100)
Diagnostics (3264)
Digital health (6)
Diversity (5)
Diversity, equity & inclusion (30)
Drug discovery (46)
Drug pricing (55)
Drug shortages (18)
Duchenne muscular dystrophy (27)
Earnings (23103)
Editorial (14)
Employer branding (8)
Employer resources (74)
Events (29932)
Executive appointments (195)
FDA (6446)
Featured Employer (11)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (2)
Funding (223)
Gene editing (20)
Generative AI (9)
Gene therapy (102)
GLP-1 (316)
Government (1606)
Grass and pollen (1)
Guidances (20)
Healthcare (7119)
Huntington's disease (10)
IgA nephropathy (11)
Immunology and inflammation (31)
Indications (9)
Infectious disease (1474)
Inflammatory bowel disease (71)
Inflation Reduction Act (5)
Influenza (23)
Intellectual property (19)
Interviews (117)
IPO (4884)
IRA (26)
Job creations (969)
Job search strategy (534)
Kidney cancer (2)
Labor market (5)
Layoffs (114)
Leadership (6)
Legal (1883)
Liver cancer (33)
Lung cancer (160)
Lymphoma (65)
Management (27)
Manufacturing (88)
MASH (36)
Medical device (4519)
Medtech (4521)
Mergers & acquisitions (7113)
Metabolic disorders (260)
Multiple sclerosis (36)
NASH (17)
Neurodegenerative disease (32)
Neuropsychiatric disorders (5)
Neuroscience (857)
NextGen: Class of 2025 (2501)
Non-profit (1859)
Northern California (739)
Obesity (129)
Opinion (71)
Ovarian cancer (22)
Pain (29)
Pancreatic cancer (32)
Parkinson's disease (60)
Partnered (7)
Patents (46)
Patient recruitment (35)
Peanut (20)
People (20388)
Pharmaceutical (13)
Pharmacy benefit managers (10)
Phase I (7282)
Phase II (13979)
Phase III (13454)
Pipeline (361)
Podcasts (37)
Policy (53)
Postmarket research (1460)
Preclinical (2493)
Press Release (32)
Prostate cancer (50)
Psychedelics (10)
Radiopharmaceuticals (85)
Rare diseases (122)
Real estate (1731)
Recruiting (27)
Regulatory (7975)
Reports (19)
Research institute (1208)
Resumes & cover letters (97)
RSV (21)
Schizophrenia (31)
Series A (50)
Series B (24)
Service/supplier (2)
Sickle cell disease (17)
Southern California (631)
Special edition (4)
Sponsored (10)
Startups (1324)
Stomach cancer (7)
Supply chain (18)
The Weekly (19)
United States (6634)
Vaccines (336)
Venture capitalists (10)
Webinars (6)
Weight loss (95)
Women's health (14)
Worklife (5)
Date
Today (58)
Last 7 days (277)
Last 30 days (1088)
Last 365 days (13219)
2025 (2137)
2024 (13437)
2023 (15080)
2022 (23355)
2021 (24118)
2020 (22033)
2019 (18765)
2018 (14413)
2017 (13023)
2016 (12408)
2015 (14370)
2014 (9990)
2013 (7940)
2012 (8583)
2011 (9140)
2010 (7961)
Location
Africa (322)
Alabama (13)
Alaska (4)
Arizona (48)
Arkansas (3)
Asia (15937)
Australia (2998)
California (1662)
Canada (702)
China (174)
Colorado (71)
Connecticut (89)
Delaware (56)
Europe (43548)
Florida (227)
Georgia (81)
Idaho (16)
Illinois (170)
India (10)
Indiana (107)
Iowa (3)
Japan (77)
Kansas (32)
Kentucky (9)
Louisiana (5)
Maine (14)
Maryland (273)
Massachusetts (1142)
Michigan (75)
Minnesota (129)
Missouri (18)
Montana (6)
Nebraska (12)
Nevada (19)
New Hampshire (28)
New Jersey (558)
New Mexico (12)
New York (588)
North Carolina (283)
Northern California (739)
Ohio (66)
Oklahoma (3)
Oregon (8)
Pennsylvania (370)
Puerto Rico (2)
Rhode Island (7)
South America (463)
South Carolina (6)
Southern California (631)
Tennessee (36)
Texas (256)
Utah (53)
Virginia (35)
Washington D.C. (15)
Washington State (207)
Wisconsin (14)
253,432 Results for "analysis group".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Analysis Group Researchers Coauthor First Study Revealing Age-Specific Incidence of Pneumococcal Disease in Young Children
Researchers from Analysis Group, a global leader in health economics and outcomes research (HEOR), have coauthored the first large-scale US study of how pneumococcal disease (PD) manifests by age group, insurance status, and sociodemographic characteristics in young children aged 0–2 years during the study period (1998–2019).
June 6, 2024
·
2 min read
Press Releases
Predictive Oncology Partners with Switzerland-Based Tecan Group Ltd. to Expand High-Throughput Drug Screening to Include Human Tumor Spheroids Using Automated Imaging and 3D Analysis
February 10, 2025
·
5 min read
Press Releases
Pharming Group to participate in March 2025 investor conference
February 28, 2025
·
1 min read
GLP-1s
Coalition Urges FDA to Act as Report Finds Illegal GLP-1 Ingredients ‘Flooding’ Into US
Many of these unlawful and unauthorized shipments were explicitly tagged for compounding, according to a new analysis. Separately, a group of state attorneys general has raised concerns about the unsafe GLP-1 drugs finding their way to American consumers.
February 21, 2025
·
4 min read
·
Tristan Manalac
Press Releases
Orion Group Financial Statement Release January–December 2024
February 25, 2025
·
16 min read
Press Releases
Pharming Group to participate in February 2025 investor conference
February 10, 2025
·
1 min read
Press Releases
Mario Biazzi, Founder of Dipharma Group, and His Contribution to the History of Nitroglycerin
February 24, 2025
·
2 min read
Press Releases
Resource Label Group Expands into Quebec with the Acquisition of Imprimerie Ste-Julie
February 10, 2025
·
2 min read
Press Releases
Pharming Group to report fourth quarter and full year 2024 financial results on March 13
February 27, 2025
·
1 min read
Press Releases
Board of Eigenmann & Veronelli Welcomes Two New Independent Directors to Support Group Growth
February 20, 2025
·
3 min read
1 of 25,344
Next
